Development and characterization of a multimeric recombinant protein using the spike protein receptor binding domain as an antigen to induce SARS-CoV-2 neutralization.
Veronica A de LimaJoão P S NunesDaniela S RosaRodrigo FerreiraMaria L V OlivaRobert Andreata-SantosMarcia Duarte-BarbosaLuiz M R JaniniJuliana T MaricatoMilena A AkamatsuPaulo L HoSergio SchenkmanPublished in: Immunity, inflammation and disease (2024)
These results add a new arsenal to combat COVID-19, as an alternative immunogen or antigen for diagnosis.